Mateusz Brzeziński

Gene Therapy

Genterapi-revolutionen: Helbredelser, gennembrud og udfordringer i genetisk medicin

Casgevy, verdens første CRISPR-baserede medicin, blev godkendt i december 2023 til behandling af seglcellesygdom og beta-thalassæmi. FDA godkendte Luxturna i 2017 for RPE65-relateret retinal dystrofi og Hemgenix i 2022 for hæmofili B. I februar 2025 fik et spædbarn første dosis af in vivo CRISPR-genterapi mod CPS1-mangel, offentliggjort i NEJM.
august 5, 2025
AI Stock Frenzy: Tech Giants’ Blowout Earnings Fuel Record Rally as Wall Street Bets Big on AI

AI-aktiefeber: Teknologigiganters rekordindtjening driver kursrally, mens Wall Street satser stort på AI

Alphabet will raise 2025 capital spending by $10 billion to $85 billion, mainly for AI chips and data centers, after beating Q2 profit forecasts and posting higher cloud revenue. Nvidia shares rose 1.7% to $174, with market value at $4.23 trillion. Intel cut 15% of staff and paused new factories despite Q2 sales of $12.9 billion. S&P 500 closed at 6,363 and Nasdaq hit records on July 24.
juli 27, 2025
1 9 10 11